Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 1 June 1990:
Vol. 248. no. 4959, pp. 1101 - 1104
DOI: 10.1126/science.2188364

Articles

Science, Vol 248, Issue 4959, 1101-1104
Copyright © 1990 by American Association for the Advancement of Science


articles

Activation of ras oncogenes preceding the onset of neoplasia

R Kumar, S Sukumar, and M Barbacid

Department of Molecular Biology, Squibb Institute for Medical Research, Princeton, NJ 08543.

The identification of ras oncogenes in human and animal cancers including precancerous lesions indicates that these genes participate in the early stages of neoplastic development. Yet, these observations do not define the timing of ras oncogene activation in the multistep process of carcinogenesis. To ascertain the timing of ras oncogene activation, an animal model system was devised that involves the induction of mammary carcinomas in rats exposed at birth to the carcinogen nitrosomethylurea. High-resolution restriction fragment length polymorphism analysis of polymerase chain reaction-amplified ras sequences revealed the presence of both H-ras and K-ras oncogenes in normal mammary glands 2 weeks after carcinogen treatment and at least 2 months before the onset of neoplasia. These ras oncogenes can remain latent within the mammary gland until exposure to estrogens, demonstrating that activation of ras oncogenes can precede the onset of neoplasia and suggesting that normal physiological proliferative processes such as estrogen-induced mammary gland development may lead to neoplasia if the targeted cells harbor latent ras oncogenes.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Development of a novel site-specific mutagenesis assay using MALDI-ToF MS (SSMA-MS).
K. I. E. McLuckie, J. H. Lamb, J. K. Sandhu, H. L. Pearson, K. Brown, P. B. Farmer, and D. J. L. Jones (2006)
Nucleic Acids Res.
   Abstract »    Full Text »    PDF »
Growth Factor-dependent AKT Activation and Cell Migration Requires the Function of c-K(B)-Ras Versus Other Cellular Ras Isoforms.
J. Liao, S. M. Planchon, J. C. Wolfman, and A. Wolfman (2006)
J. Biol. Chem. 281, 29730-29738
   Abstract »    Full Text »    PDF »
Effects of dietary folate on the development and progression of mammary tumors in rats.
J. Kotsopoulos, A. Medline, R. Renlund, K.-J. Sohn, R. Martin, S. W. Hwang, S. Lu, M. C. Archer, and Y.-I. Kim (2005)
Carcinogenesis 26, 1603-1612
   Abstract »    Full Text »    PDF »
Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents.
E. Barletta, G. Gorini, P. Vineis, L. Miligi, L. Davico, G. Mugnai, S. Ciolli, F. Leoni, M. Bertini, G. Matullo, et al. (2004)
Carcinogenesis 25, 749-755
   Abstract »    Full Text »    PDF »
H-ras oncogene mutations during development of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced rat mammary gland cancer.
M. Yu and E. G. Snyderwine (2002)
Carcinogenesis 23, 2123-2128
   Abstract »    Full Text »    PDF »
Tumor DNA in Plasma at Diagnosis of Breast Cancer Patients Is a Valuable Predictor of Disease-free Survival.
J. M. Silva, J. Silva, A. Sanchez, J. M. Garcia, G. Dominguez, M. Provencio, L. Sanfrutos, E. Jareno, A. Colas, P. Espana, et al. (2002)
Clin. Cancer Res. 8, 3761-3766
   Abstract »    Full Text »    PDF »
Melatonin: From Basic Research to Cancer Treatment Clinics.
Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman (2002)
J. Clin. Oncol. 20, 2575-2601
   Abstract »    Full Text »    PDF »
p53 Mutation in Plasma DNA and Its Prognostic Value in Breast Cancer Patients.
Z.-M. Shao, J. Wu, Z.-Z. Shen, and M. Nguyen (2001)
Clin. Cancer Res. 7, 2222-2227
   Abstract »    Full Text »    PDF »
ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.
T. A. Thompson, J. D. Haag, and M. N. Gould (2000)
Carcinogenesis 21, 1917-1922
   Abstract »    Full Text »    PDF »
Estrogen Inducibility of c-Ha-ras Transcription in Breast Cancer Cells. IDENTIFICATION OF FUNCTIONAL ESTROGEN-RESPONSIVE TRANSCRIPTIONAL REGULATORY ELEMENTS IN EXON 1/INTRON 1 OF THE c-Ha-ras GENE.
V. Pethe and P. V. M. Shekhar (1999)
J. Biol. Chem. 274, 30969-30978
   Abstract »    Full Text »    PDF »
Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
S.-J. C. Wei, R. L. Chang, K. A. Merkler, M. Gwynne, X. X. Cui, B. Murthy, M.-T. Huang, J.-G. Xie, Y.-P. Lu, Y.-R. Lou, et al. (1999)
Carcinogenesis 20, 1689-1696
   Abstract »    Full Text »    PDF »
Digital PCR.
B. Vogelstein and K. W. Kinzler (1999)
PNAS 96, 9236-9241
   Abstract »    Full Text »    PDF »
Presence of Tumor DNA in Plasma of Breast Cancer Patients: Clinicopathological Correlations.
J. M. Silva, G. Dominguez, J. M. Garcia, R. Gonzalez, M. J. Villanueva, F. Navarro, M. Provencio, S. San Martin, P. Espana, and F. Bonilla (1999)
Cancer Res. 59, 3251-3256
   Abstract »    Full Text »    PDF »
Fast repair of O6-ethylguanine, but not O6-methylguanine, in transcribed genes prevents mutation of H-ras in rat mammary tumorigenesis induced by ethylnitrosourea in place of methylnitrosourea.
J. Engelbergs, J. Thomale, A. Galhoff, and M. F. Rajewsky (1998)
PNAS 95, 1635-1640
   Abstract »    Full Text »    PDF »
Brief Communication: P53 Accumulation in N-Methyl-N-Nitrosourea-Induced Rat Mammary Tumors.
K. A. Crist, R. D. Fuller, B. Chaudhuri, P. Chaudhuri, and Ming You (1996)
Toxicol Pathol 24, 370-375
   Abstract »    PDF »
Polymerase Chain Reaction and In Situ Hybridization: Applications in Toxicological Pathology.
D. E. Malarkey and R. R. Maronpot (1996)
Toxicol Pathol 24, 13-23
   Abstract »    PDF »
H-ras Oncogene Mutation and Human Papillomavirus Infection in Oral Carcinomas.
J. A. Anderson, J. C. Irish, C. M. McLachlin, and B. Y. Ngan (1994)
Arch Otolaryngol Head Neck Surg 120, 755-760
   Abstract »    PDF »
PCR-based approaches for detection of mutated ras genes..
A D van Mansfeld and J L Bos (1992)
Genome Res. 1, 211-216
   PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)